Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025